Related Experiment Video
Updated: Feb 7, 2026

Monitoring Spatial Segregation in Surface Colonizing Microbial Populations
Published on: October 29, 2016
EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains
Rachana Pattani Ramachandran1, Felipe Vences-Catalán2, Dan Wiseman1
1Department of Cell and Developmental Biology, Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.
Enteropathogenic Escherichia coli (EPEC) uses EspH to recruit CD81, then suppresses the Erk pathway for gut colonization. CD81 may counteract this suppression, influencing EPEC survival.
Area of Science:
- Microbiology
- Cell Biology
- Immunology
Background:
- Enteropathogenic Escherichia coli (EPEC) are human enteric pathogens employing a type III secretion system (T3SS).
- EPEC translocates effector proteins into host intestinal epithelial cells to induce attaching-and-effacing (A/E) lesions.
Purpose of the Study:
- To identify novel EPEC effectors and elucidate their roles in host-pathogen interactions.
- To investigate the function of the EPEC effector EspH in modulating host cell signaling pathways, specifically MAPK/Erk.
- To explore the interplay between EspH, the tetraspanin CD81, and Erk signaling during EPEC infection.
Main Methods:
- Identification and characterization of the EPEC effector EspH.
- Analysis of CD81 recruitment to EPEC infection sites.
- Investigation of EspH's effect on the MAPK/Erk signaling pathway using cell-based assays.
- Examination of Erk signaling in CD81-deficient cells during EPEC infection.
- Assessment of EspH localization relative to CD81 microdomains over time.
Main Results:
- EspH was identified as an EPEC effector that recruits CD81 to infection sites.
- EspH suppresses the MAPK/Erk signaling pathway, particularly at later infection times.
- Suppression of Erk by EspH is more potent in CD81-deficient cells, indicating a counteracting role for CD81.
- EspH's localization shifts from CD81 microdomains to exclusion from them over the course of infection.
- EspH selectively inhibits tumor necrosis factor alpha (TNF-α)-induced Erk signaling.
Conclusions:
- EPEC utilizes EspH to manipulate host cell signaling by initially recruiting CD81 and subsequently inhibiting Erk pathway activation.
- CD81 acts as a positive regulator of Erk signaling, counteracting EspH-mediated suppression.
- The dynamic interaction between EspH and CD81 influences Erk signaling, potentially facilitating EPEC colonization and survival.
- EPEC's suppression of Erk and TNF-α signaling impacts innate immunity and cell survival, promoting pathogen persistence in the gut.
Related Concept Videos
Law of Segregation
Segregation in Fresh Concrete
Depth Perception and Spatial Vision
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

